GEORGE ANSOANUUR: Open Payments
NPI 1902292105 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 12 payments from 8 companies in 2025. Trend: 2023 $118 · 2024 $26 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $325 |
| Medtronic, Inc. | 2 | $151 |
| Boston Scientific Corporation | 1 | $148 |
| AstraZeneca Pharmaceuticals LP | 2 | $125 |
| Novo Nordisk Inc | 2 | $114 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $106 |
| SPR Therapeutics, Inc | 1 | $59 |
| Averitas Pharma Inc. | 1 | $25 |
Products named: PROCLAIM, Clinical Trial Product, INTELLIS ADAPTIVESTIM, JOURNAVX, SPRINT PNS System, INCEPTIV, QUTENZA.
Industry payments across TX — which companies pay providers there.
